Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Cancer & Clinical Oncology|May 1, 1985
Sequential methotrexate and 5-fluorouracil in the treatment of non-small cell carcinoma of the lungC D Wood, M L Slevin, B A Ponder, et al.
Cancer Treatment Reports|April 1, 1987
High-dose cytarabine in small cell lung cancerR J Osborne, P I Clark, M L Slevin, et al.
Lancet (London, England)|May 11, 1985
Morphine-6-glucuronide, an important metaboliteS P Joel, R J Osborne, N S Nixon, et al.
British Journal of Cancer|January 1, 1988
Who should measure quality of life, the doctor or the patient?M L Slevin, H Plant, D Lynch, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1986
Evaluating and designing cancer chemotherapy treatment using mathematical modelsB G Birkhead, W M Gregory, M L Slevin, et al.
Cancer Research|February 15, 1991
A mathematical model relating response durations to amount of subclinical resistant diseaseW M Gregory, M A Richards, M L Slevin, et al.
British Journal of Cancer|October 10, 2002
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimenS Slater, J Shamash, P Wilson, et al.
Journal of Pharmaceutical Sciences|December 18, 2001
Limited phase I study of morphine-3-glucuronideR T Penson, S P Joel, S Clark, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1992
The treatment of microscopic residual ovarian cancer with intraperitoneal interferon: a clinical and flow cytometric studyJ S Whelan, P A van Dam, J H Shepherd, et al.
British Journal of Cancer|October 1, 1994
Lack of effect of interferon alpha 2a upon fluorouracil pharmacokineticsM T Seymour, N Patel, A Johnston, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer & Clinical Oncology|May 1, 1985
Sequential methotrexate and 5-fluorouracil in the treatment of non-small cell carcinoma of the lungC D Wood, M L Slevin, B A Ponder, et al.
Cancer Treatment Reports|April 1, 1987
High-dose cytarabine in small cell lung cancerR J Osborne, P I Clark, M L Slevin, et al.
Lancet (London, England)|May 11, 1985
Morphine-6-glucuronide, an important metaboliteS P Joel, R J Osborne, N S Nixon, et al.
British Journal of Cancer|January 1, 1988
Who should measure quality of life, the doctor or the patient?M L Slevin, H Plant, D Lynch, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1986
Evaluating and designing cancer chemotherapy treatment using mathematical modelsB G Birkhead, W M Gregory, M L Slevin, et al.
Cancer Research|February 15, 1991
A mathematical model relating response durations to amount of subclinical resistant diseaseW M Gregory, M A Richards, M L Slevin, et al.
British Journal of Cancer|October 10, 2002
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimenS Slater, J Shamash, P Wilson, et al.
Journal of Pharmaceutical Sciences|December 18, 2001
Limited phase I study of morphine-3-glucuronideR T Penson, S P Joel, S Clark, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1992
The treatment of microscopic residual ovarian cancer with intraperitoneal interferon: a clinical and flow cytometric studyJ S Whelan, P A van Dam, J H Shepherd, et al.
British Journal of Cancer|October 1, 1994
Lack of effect of interferon alpha 2a upon fluorouracil pharmacokineticsM T Seymour, N Patel, A Johnston, et al.
Pageof 14